What Does "Good" Look Like In A Decentralized Clinical Trial?

By Dr. Graham Wylie, Medical Research Network

I recently had the pleasure of being invited to a panel discussion webinar run by the AVOCA Quality Consortium (to which MRN is a member) as part of its “Leading Change” program for members, discussing DCT, with sites and sponsors also represented on the panel.  The topics are proposed by the members, and DCT was high on their list.  As you would expect from an AQC audience, the focus of the discussion was heavily about risk.  As part of the preparation, I was asked to think about “What does good look like?”.  This sounded great – but was really hard to prepare for, as I was not sure what those in the audience were concerned about.  “Good” could cover anything!